Delayed pre-conditioning by 3-nitropropionic acid prevents 3,4-methylenedioxymetamphetamine-induced 5-HT deficits

Journal of Neurochemistry

Volumn 114, Issue 3, 2010, Pages 843-852

  Puerta, Elena ^a   Pastor, Fiona ^a   Dvoracek, Jan ^a   De Saavedra, María D M ^a   Goñi Allo, Beatriz ^a   Jordán, Joaquín ^b   Hervias, Isabel ^a   Aguirre, Norberto ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Department of Medical Sciences School of Medicine University of Castilla La ^*  (Spain)

Author keywords

3,4 methylenedioxymethamphetamine; 3 nitropropionic acid; 5 hydroxytryptamine (serotonin); mitochondrial ATP sensitive potassium channels; nitric oxide; pre conditioning

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 NITROPROPIONIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLOHEXIMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; N(G) PROPYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; 3-NITROPROPIONIC ACID; NEUROPROTECTIVE AGENT; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; SEROTONIN RECEPTOR AFFECTING AGENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; CORPUS STRIATUM; CYTOTOXICITY; DRUG EFFECT; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SEROTONIN BRAIN LEVEL; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DEFICIENCY; MALE; METABOLISM; PHYSIOLOGY; TOXICITY; WISTAR RAT;

RATTUS;

ANIMALS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; PROPIONATES; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS;

EID: 77954335052     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06808.x     Document Type: Article

References (65)

1. Aguirre N., Ballaz S., Lasheras B. Del Río J. (1998) MDMA (''Ecstasy'') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion. Eur. J. Pharmacol. 346, 181 188.
2. Alderton W. K., Cooper C. E. Knowles R. G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593 615.
3. Arthur P. G., Lim S. C., Meloni B. P., Munns S. E., Chan A. Knuckey N. W. (2004) The protective effect of hypoxic preconditioning on cortical neuronal cultures is associated with increases in the activity of several antioxidant enzymes. Brain Res. 1017, 146 154.
4. Atochin D. N., Clark J., Demchenko I. T., Moskowitz M. A. Huang P. L. (2003) Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke 34, 1299 1303.
5. Basgut B., Aypar E., Basgut E., Akin K. O., Kilic N. Cakici I. (2008) The mechanism of the late preconditioning effect of 3-nitropropionic acid. Arch. Pharm. Res. 31, 1257 1263.
6. Bhide N. S., Lipton J. W., Cunningham J. I., Yamamoto B. K. Gudelsky G. A. (2009) Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Res. 1286, 32 41.
7. Busija D. W., Gaspar T., Domoki F., Katakam P. V. Bari F. (2008) Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv. Drug Deliv. Rev. 60, 1471 1477.
8. Cadet J. L., McCoy M. T., Cai N. S., Krasnova I. N., Ladenheim B., Beauvais G., Wilson N., Wood W., Becker K. G. Hodges A. B. (2009) Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS ONE 4, e7812.
9. Centeno J. M., Orti M., Salom J. B., Sick T. J. Perez-Pinzon M. A. (1999) Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices. Brain Res. 836, 62 69.
10. Chiueh C. C., Andoh T. Chock P. B. (2005) Induction of thioredoxin and mitochondrial survival proteins mediates preconditioning-induced cardioprotection and neuroprotection. Ann. N.Y. Acad. Sci. 1042, 403 418.
11. Cho S., Park E. M., Zhou P., Frys K., Ross M. E. Iadecola C. (2005) Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J. Cereb. Blood Flow Metab. 25, 493 501.
12. Danielisová V., Némethová M., Gottlieb M. Burda J. (2005) Changes of endogenous antioxidant enzymes during ischemic tolerance acquisition. Neurochem. Res. 30, 559 565.
13. Domoki F., Perciaccante J. V., Veltkamp R., Bari F. Busija D. W. (1999) Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 30, 2713 2718.
14. Gidday J. M., Shah A. R., Maceren R. G., Wang Q., Pelligrino D. A., Holtzman D. M. Park T. S. (1999) Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J. Cereb. Blood Flow Metab. 19, 331 340.
15. Goñi-Allo B., Ramos M., Hervias I., Lasheras B. Aguirre N. (2006) Studies on striatal neurotoxicity caused by the 3,4- methylenedioxymethamphetamine/malonate combination: implications for serotonin/dopamine interactions. J. Psychopharmacol. 20, 245 256.
16. Goñi-Allo B., Puerta E., Hervias I., Di Palma R., Ramos M., Lasheras B. Aguirre N. (2007) Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Eur. J. Pharmacol. 562, 198 207.
17. Goñi-Allo B., O Mathùna B., Segura M., Puerta E., Lasheras B., de la Torre R. Aguirre N. (2008a) The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. Psychopharmacology (Berl.) 197, 263 278.
18. Goñi-Allo B., Puerta E., Ramos M., Lasheras B., Jordan J. Aguirre N. (2008b) Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: role of mitochondrial ATP-sensitive potassium channels, Akt and ERK. J. Neurochem. 104, 914 925.
19. Gonzalez-Zulueta M., Feldman A. B., Klesse L. J., Kalb R. G., Dillman J. F., Parada L. F., Dawson T. M. Dawson V. L. (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl Acad. Sci. USA 97, 436 441.
20. Hervias I., Lasheras B. Aguirre N. (2000) 2-Deoxy-d-Glucose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. J. Neurochem. 75, 982 990.
21. Heurteaux C., Lauritzen I., Widmann C. Lazdunski M. (1995) Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc. Natl Acad. Sci. USA 92, 4666 4670.
22. Horiguchi T., Kis B., Rajapakse N., Shimizu K. Busija D. W. (2003) Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 34, 1015 1020.
23. Hoyte L. C., Papadakis M., Barber P. A. Buchan A. M. (2006) Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res. 1121, 231 237.
24. Huang P. L. (2004) Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 36, 323 329.
25. Iravani M. M., Kashefi K., Mander P., Rose S. Jenner P. (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110, 49 58.
26. Jones N. M. Bergeron M. (2004) Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J. Neurochem. 89, 157 167.
27. Kariko K., Weissman D. Welsh F. A. (2004) Inhibition of toll-like receptor and cytokine signalling-a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24, 1288 1304.
28. Kirino T. (2002) Ischemic tolerance. J. Cereb. Blood Flow Metab. 22, 1283 1296.
29. Kis B., Nagy K., Snipes J. A., Rajapakse N. C., Horiguchi T., Grover G. J. Busija D. W. (2004) The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport 15, 345 349.
30. Kitagawa K., Matsumoto M., Tagaya M. et al. (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528, 21 24.
31. Klamer D., Engel J. A. Svensson L. (2004) The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur. J. Pharmacol. 503, 103 107.
32. Kobayashi S., Harris V. A. Welsh F. A. (1995) Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15, 721 727.
33. Kodani E., Xuan Y. T., Takano H., Shinmura K., Tang X. L. Bolli R. (2002) Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits. Circulation 105, 3046 3052. (Pubitemid 34693840)
34. Lin Y. F., Raab-Graham K., Jan Y. N. Jan L. Y. (2004) NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc. Natl Acad. Sci. USA 101, 7799 77804.
35. Mayanagi K., Gaspar T., Katakam P. V., Kis B. Busija D. W. (2007) The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 27, 348 355.
36. Meller R., Cameron J. A., Torrey D. J., Clayton C. E., Ordonez A. N., Henshall D. C., Minami M., Schindler C. K., Saugstad J. A. Simon R. P. (2006) Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons. J. Biol. Chem. 281, 7429 7436.
37. Nagy K., Kis B., Rajapakse N. C., Bari F. Busija D. W. (2004) Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation. J. Neurosci. Res. 76, 697 704.
38. Nakase H., Heimann A., Uranishi R., Riepe M. W. Kempski O. (2000) Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor. Neurosci. Lett. 290, 105 108.
39. Ockaili R., Emani V. R., Okubo S., Brown M., Krottapalli K. Kukreja R. C. (1999) Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am. J. Physiol. 277, H2425 H2434.
40. Ockaili R. A., Bhargava P. Kukreja R. C. (2001) Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. Am. J. Physiol. Heart Circ. Physiol. 280, H2406 H2411.
41. O'Rourke B. (2004) Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res. 94, 420 342.
42. O'Shea E., Orio L., Escobedo I., Sanchez V., Camarero J., Green A. R. Colado M. I. (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. Br. J. Pharmacol. 148, 778 785.
43. Perez-Pinzon M. A. Born J. G. (1999) Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience 89, 453 459.
44. Perez-Pinzon M. A., Xu G. P., Dietrich W. D., Rosenthal M. Sick T. J. (1997) Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 17, 175 182.
45. Piper B. J., Vu H. L., Safain M. G., Oliver A. J. Meyer J. S. (2006) Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. J. Pharmacol. Exp. Ther. 317, 838 849.
46. Puerta E., Hervias I. Aguirre N. (2009a) On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg. Neuropsychobiology 60, 119 129.
47. Puerta E., Hervias I., Goñi-Allo B., Lasheras B., Jordan J. Aguirre N. (2009b) Phosphodiesterase 5 inhibitors prevent 3,4- methylenedioxymethamphetamine-induced 5-HT deficits in the rat. J. Neurochem. 108, 755 766.
48. Riepe M. W., Esclaire F., Kasischke K., Schreiber S., Nakase H., Kempski O., Ludolph A. C., Dirnagl U. Hugon J. (1997) Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning". J. Cereb. Blood Flow Metab. 17, 257 264.
49. Samavati L., Monick M. M., Sanlioglu S., Buettner G. R., Oberley L. W. Hunninghake G. W. (2002) Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am. J. Physiol. Cell Physiol. 283, C273 C281.
50. Sanchez V., Camarero J., Esteban B., Peter M. J., Green A. R. Colado M. I. (2001) The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br. J. Pharmacol. 134, 46 57.
51. Sasaki N., Sato T., Ohler A., O'Rourke B. Marban E. (2000) Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101, 439 445.
52. Scorziello A., Santillo M., Adornetto A., Dell'aversano C., Sirabella R., Damiano S., Canzoniero L. M., Renzo G. F. Annunziato L. (2007) NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via Ras/ERK1/2 pathway. J. Neurochem. 103, 1472 1480.
53. Shamloo M., Rytter A. Wieloch T. (1999) Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93, 81 88.
54. Shankaran M., Yamamoto B. K. Gudelsky G. A. (1999) Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385, 103 110.
55. Shen J., Ma S., Chan P., Lee W., Fung P. C., Cheung R. T., Tong Y. Liu K. J. (2006) Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J. Neurochem. 96, 1078 1089.
56. Stagliano N. E., Perez-Pinzon M. A., Moskowitz M. A. Huang P. L. (1999) Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 19, 757 761.
57. Stenzel-Poore M. P., Stevens S. L., Xiong Z. et al. (2003) Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362, 1028 1037.
58. Sugino T., Nozaki K., Takagi Y. Hashimoto N. (1999) 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci. Lett. 259, 9 12.
59. Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H. Hallenbeck J. M. (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267 270.
60. Teshima Y., Akao M., Li R. A., Chong T. H., Baumgartner W. A., Johnston M. V. Marban E. (2003) Mitochondrial ATP-sensitive potassium channel activation protects cerebellar granule neurons from apoptosis induced by oxidative stress. Stroke 34, 1796 1802.
61. Turan N., Csonka C., Csont T., Giricz Z., Fodor G., Bencsik P., Gyöngyösi M., Cakici I. Ferdinandy P. (2006) The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc. Res. 70, 384 390.
62. Wiegand F., Liao W., Busch C. et al. (1999) Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 1229 1237.
63. Xu Z., Ji X. Boysen P. G. (2004) Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am. J. Physiol. Heart Circ. Physiol. 286, H1433 H1440.
64. Zheng S. Zuo Z. (2004) Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol. Pharmacol. 65, 1172 1180.
65. Zhu H. C., Gao X. Q., Xing Y., Sun S. G., Li H. G. Wang Y. F. (2004) Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. J. Mol. Neurosci. 24, 299 305.